Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stauffer

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
International Journal of Laboratory Hematology|February 27, 2025
Liquid Biopsy for Enhanced Specificity in Identifying Somatic Mutations in Aggressive Non-Hodgkin Large B-Cell Lymphoma: A Comparative Study of Cell-Free DNA and Formalin-Fixed Paraffin-Embedded TissueGayaththri Vimalathas, Oriane Cédile, Marie Louise Grube Kjeldsen, et al.
Leukemia Research|April 8, 2011
High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosisHans Carl Hasselbalch, Vibe Skov, Thomas Stauffer Larsen, et al.
Hematology (Amsterdam, Netherlands)|November 28, 2009
Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remissionThomas Stauffer Larsen, Michael Boe Møller, Karin de Stricker, et al.
Plos One|November 15, 2014
Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progressionHans Carl Hasselbalch, Mads Thomassen, Caroline Hasselbalch Riley, et al.
Leukemia & Lymphoma|March 21, 2017
Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based studyHenrik Cederleuf, Lasse Hjort Jakobsen, Fredrik Ellin, et al.
Annals of Hematology|May 29, 2023
Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT eraJelena Jelicic, Dennis Lund Hansen, Sarah Sand Carlsen, et al.
Clinical Epidemiology|November 9, 2016
The Danish National Chronic Myeloid Neoplasia RegistryMarie Bak, Else Helene Ibfelt, Thomas Stauffer Larsen, et al.
Annals of Hematology|July 18, 2019
Pixantrone beyond monotherapy: a reviewCristina Barrenetxea Lekue, Silvina Grasso Cicala, Sirpa Leppä, et al.
Ugeskrift for Laeger|May 14, 2015
[New disease markers within the chronic myeloproliferative neoplasms]Morten Orebo Holmström, Lukas Frans Ocias, Klaus Kallenbach, et al.
Acta Neurochirurgica|March 8, 2022
Diagnosis, treatment, and outcome of primary CNS lymphoma-a single-center experienceJoakim Wismann, Rune Hørlykke Sommer-Sørensen, Mikkel Seremet Kofoed, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
International Journal of Laboratory Hematology|February 27, 2025
Liquid Biopsy for Enhanced Specificity in Identifying Somatic Mutations in Aggressive Non-Hodgkin Large B-Cell Lymphoma: A Comparative Study of Cell-Free DNA and Formalin-Fixed Paraffin-Embedded TissueGayaththri Vimalathas, Oriane Cédile, Marie Louise Grube Kjeldsen, et al.
Leukemia Research|April 8, 2011
High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosisHans Carl Hasselbalch, Vibe Skov, Thomas Stauffer Larsen, et al.
Hematology (Amsterdam, Netherlands)|November 28, 2009
Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remissionThomas Stauffer Larsen, Michael Boe Møller, Karin de Stricker, et al.
Plos One|November 15, 2014
Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progressionHans Carl Hasselbalch, Mads Thomassen, Caroline Hasselbalch Riley, et al.
Leukemia & Lymphoma|March 21, 2017
Outcome of peripheral T-cell lymphoma in first complete remission: a Danish-Swedish population-based studyHenrik Cederleuf, Lasse Hjort Jakobsen, Fredrik Ellin, et al.
Annals of Hematology|May 29, 2023
Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT eraJelena Jelicic, Dennis Lund Hansen, Sarah Sand Carlsen, et al.
Clinical Epidemiology|November 9, 2016
The Danish National Chronic Myeloid Neoplasia RegistryMarie Bak, Else Helene Ibfelt, Thomas Stauffer Larsen, et al.
Annals of Hematology|July 18, 2019
Pixantrone beyond monotherapy: a reviewCristina Barrenetxea Lekue, Silvina Grasso Cicala, Sirpa Leppä, et al.
Ugeskrift for Laeger|May 14, 2015
[New disease markers within the chronic myeloproliferative neoplasms]Morten Orebo Holmström, Lukas Frans Ocias, Klaus Kallenbach, et al.
Acta Neurochirurgica|March 8, 2022
Diagnosis, treatment, and outcome of primary CNS lymphoma-a single-center experienceJoakim Wismann, Rune Hørlykke Sommer-Sørensen, Mikkel Seremet Kofoed, et al.
Pageof 11